Apple Plans Brain Signal Control for Devices in 2025

Apple is advancing brain-computer interface (BCI) technology to enable users to control iPhones, iPads, and Apple Vision Pro devices using neural signals via an implantable device developed in partnership with Synchron. This innovation aims to significantly enhance accessibility for users with mobility impairments such as paralysis and ALS, potentially unlocking new user bases and transforming human-device interaction. The technology, which includes features like Eye and Head Tracking and Switch Control for the neural interface, is anticipated to start controlled trials later in 2025. The announcement has generated mixed reactions online, with excitement about the potential benefits and concerns regarding implant safety. Financially, Apple's stock has responded positively, with analysts projecting a roughly 10% upside and an "Outperform" rating, though some valuation models suggest only a slim margin of safety. Additionally, the BCI initiative could influence adjacent markets, including AI-focused cryptocurrencies and blockchain health technologies, as investor interest grows in neural tech integration across sectors.